ONY Biotech is pleased to announce the commercial availability of AerVia®, the first and only supraglottic airway device specifically designed for neonates.
While endotracheal intubation has been the standard of neonatal airway management for decades, less invasive alternatives, like supraglottic airway devices, are growing in popularity. However, neonatal clinicians have not had access to appropriate size-supraglottic airways, especially for the smallest babies – until now. AerVia® offers a less invasive alternative that may reduce the complexity of airway access and the potential for procedural trauma, particularly in emergent or transport situations.
Designed for the Tiniest Patients
AerVia® is not simply a scaled-down version of an adult laryngeal mask airway, it is purpose-built for neonatal anatomy. Its design supports reliable placement, effective airway patency, and procedural efficiency in high-stress, time-sensitive environments.
Why AerVia®?
- Neonatal-Specific Design – Sized and shaped for the neonatal airway.
- Rapid, Intuitive Insertion – Supports quick placement in time-sensitive scenarios.
- Minimally Invasive Alternative – Reduces reliance on intubation where appropriate.
- Versatile Utility – Suited for delivery rooms, NICUs, resuscitation teams, and neonatal transport.
Now Available for Purchase
AerVia® is now available for purchase through AerVia.com. To ensure proper implementation and support, purchasing is limited to registered healthcare providers and institutions.
Register to access ordering: Once registered, you’ll gain access to ordering and customer support from our team.
Support Safer, Simpler Neonatal Airway Management
By adding AerVia® to your airway management toolkit, your team will be among the first to implement a neonatal-specific supraglottic solution, advancing respiratory care where it’s needed most.
For clinical support, training inquiries, or implementation guidance, please contact ONY Biotech directly at [email protected].